Biosimilars are becoming indispensable in the management of multiple diseases although concerns still exist

Brian Godman*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

5 Citations (Scopus)
Original languageEnglish
Pages (from-to)5-10
Number of pages6
JournalBangladesh Journal of Medical Science
Volume20
Issue number1
DOIs
Publication statusPublished - 2021

Keywords

  • Adalimumab
  • Biosimilars
  • Demand-side measures
  • Generics
  • Insulin glargine
  • Savings

Cite this